Connor, Clark & Lunn Investment Management (CC&L)’s iRadimed IRMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,982	Closed	-$426K	–	1648
2025 Q3	$426K	Sell	5,982 -6,197	-51%	-$413K	﹤0.01%	1291
2025 Q2	$728K	Sell	12,179 -2,512	-17%	-$138K	﹤0.01%	1146
2025 Q1	$771K	Sell	14,691 -1,615	-10%	-$90.7K	﹤0.01%	1035
2024 Q4	$897K	Buy	16,306 +2,921	+22%	+$154K	﹤0.01%	977
2024 Q3	$673K	Buy	13,385 +4,708	+54%	+$217K	﹤0.01%	1007
2024 Q2	$381K	Buy	8,677 +3,743	+76%	+$159K	﹤0.01%	1123
2024 Q1	$217K	Buy	4,934 +408	+9%	+$18K	﹤0.01%	1378
2023 Q4	$215K	Sell	4,526 -2,162	-32%	-$90.9K	﹤0.01%	1249
2023 Q3	$297K	Sell	6,688 -1,665	-20%	-$77.4K	﹤0.01%	1146
2023 Q2	$399K	Buy	+8,353	New	+$377K	﹤0.01%	1044
2018 Q4	–	Sell	-5,600	Closed	-$208K	–	993
2018 Q3	$208K	Buy	+5,600	New	+$151K	﹤0.01%	848